Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
Document Type
- Journal article (22)
Language
- English (22) (remove)
Keywords
- Biologie (5)
- actinomycetes (5)
- sponges (4)
- marine sponge (3)
- marine sponges (3)
- streptomyces (3)
- NRPS (2)
- Streptomyces (2)
- Streptomyces axinellae (2)
- anti-parasitic (2)
- anti-trypanosomal (2)
- bioactivity (2)
- cysteine protease (2)
- dereplication (2)
- genome analysis (2)
- metabolomics (2)
- protease inhibition (2)
- tetromycin (2)
- A-D (1)
- Actinokineospora (1)
- Agrobacterium (1)
- Allorhizobium vitis (1)
- Candidate Phylum Poribacteria (1)
- FISH-CLEM (1)
- Llullaillaco Volcano (1)
- Meeresschwämme (1)
- Micromonospora (1)
- NMR (1)
- NMR fingerprint (1)
- PKS I (1)
- PKS II (1)
- Porifera (1)
- Red sea (1)
- Spheciospongia vagabunda (1)
- Strahlenpilze (1)
- Subtercola vilae (1)
- Ti plasmids (1)
- Vitis vinifera (1)
- Williamsia sp. ARP1 (1)
- actinobacteria (1)
- actinosporins (1)
- adaption (1)
- annotation (1)
- anti-infective (1)
- anti-protease (1)
- anti-trypanosoma (1)
- antioxidant (1)
- arabidopsis thaliana (1)
- aspergillus fumigatus (1)
- assembly (1)
- bacterial community (1)
- biofilms (1)
- biology (1)
- biosynthesis (1)
- bryozoan bugula-neritina (1)
- butenolide (1)
- cathepsin (1)
- cathepsin-L (1)
- cell compartmentation (1)
- co-cultivation (1)
- cold adaptation (1)
- contact lens (1)
- cyclic dipeptide (1)
- cytotoxic (1)
- de novo sequenced genomes (1)
- diazepinomicin (1)
- discovery (1)
- draft genome (1)
- drug metabolism (1)
- drugs (1)
- genomic analysis (1)
- genomic databases (1)
- high resolution visualisation (1)
- in-vitro (1)
- induced metabolites (1)
- malaria parasites (1)
- marine (1)
- marine Synechococcus strains (1)
- marine bacteria (1)
- mass spectrometry (1)
- medicine (1)
- metabolic profiling (1)
- metabolites (1)
- metagenomics (1)
- microbial communities (1)
- multivariate analysis (1)
- natural products (1)
- next generation sequencing (1)
- nonribosomal peptide synthetase (1)
- phyllosphere (1)
- phylogenetic (1)
- phylogenetic analysis (1)
- phylogenetics (1)
- plakortide E. (1)
- plakortis halichondroides (1)
- polyketide synthase gene (1)
- polyvinyl chloride (1)
- protease inhibitor (1)
- protein domains (1)
- reveals (1)
- rhodesain (1)
- ribosomal RNA (1)
- ribosomal RNA genes (1)
- secondary metabolites (1)
- secondary metabolomics (1)
- sequence analysis (1)
- single cell (1)
- slowly-binding reversible inhibitor (1)
- spacer sequences (1)
- sponge holicolona-simulans (1)
- sponge-associated actinomyetes (1)
- staphilococci (1)
- staurosporine (1)
- symbiotic bacteria (1)
- systematic affiliation (1)
- transcriptional profiling (1)
- trypanosoma brucei (1)
- valinomycin (1)
- vertical transmission (1)
- web server (1)
- whole genome sequencing (1)
Institute
- Julius-von-Sachs-Institut für Biowissenschaften (21)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Pharmakologie und Toxikologie (2)
- Augenklinik und Poliklinik (1)
- Center for Computational and Theoretical Biology (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Organische Chemie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
EU-Project number / Contract (GA) number
- 311932 (4)
Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 μM; staurosporine IC50 5.30 μM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 μM; staurosporine IC50 0.022 μM; butenolide IC50 31.77 μM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.
Among the Microbacteriaceae the species of Subtercola and Agreia form closely associated clusters. Phylogenetic analysis demonstrated three major phylogenetic branches of these species. One of these branches contains the two psychrophilic species Subtercola frigoramans and Subtercola vilae, together with a larger number of isolates from various cold environments. Genomic evidence supports the separation of Agreia and Subtercola species. In order to gain insight into the ability of S. vilae to adapt to life in this extreme environment, we analyzed the genome with a particular focus on properties related to possible adaptation to a cold environment. General properties of the genome are presented, including carbon and energy metabolism, as well as secondary metabolite production. The repertoire of genes in the genome of S. vilae DB165\(^T\) linked to adaptations to the harsh conditions found in Llullaillaco Volcano Lake includes several mechanisms to transcribe proteins under low temperatures, such as a high number of tRNAs and cold shock proteins. In addition, S. vilae DB165\(^T\) is capable of producing a number of proteins to cope with oxidative stress, which is of particular relevance at low temperature environments, in which reactive oxygen species are more abundant. Most important, it obtains capacities to produce cryo-protectants, and to combat against ice crystal formation, it produces ice-binding proteins. Two new ice-binding proteins were identified which are unique to S. vilae DB165\(^T\). These results indicate that S. vilae has the capacity to employ different mechanisms to live under the extreme and cold conditions prevalent in Llullaillaco Volcano Lake.